The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial intelligence, emphasizing the need to reduce regulatory burdens that hinder innovation and increase costs, while ensuring patient safety and data privacy. The letter outlines four key recommendations: synchronizing AI policies with existing frameworks to avoid redundancy, removing regulatory barriers such as fragmented privacy laws and outdated substance use disorder regulations, ensuring safe and effective AI use through clinician involvement in decision loops that impact care delivery and consistent standards for third-party vendors, and addressing organizational and infrastructural challenges by aligning incentives and investing in digital access and literacy. The AHA encourages OSTP to ensure balanced, flexible policies that support innovation and improve care delivery across the health system. 

Headline
The AHA Nov. 3 launched a new webpage, Artificial Intelligence Policy and Advocacy, featuring AHA policy letters, statements, fact sheets, news and other…
Headline
The West Health Accelerator at the AHA’s Health Research & Educational Trust will host a virtual session Oct. 29 at 2:30 p.m. ET on how hospitals are…
Headline
The AHA provided recommendations to the Food and Drug Administration Oct. 19 on potential regulatory frameworks for generative artificial intelligence-enabled…
Headline
The Agency for Healthcare Research and Quality Oct. 7 announced the launch of the Super Intelligence for Healthcare Improvement Initiative, a two-part…
Headline
An AHA blog published Oct. 5 responds to a Blue Cross Blue Shield Association report suggesting that hospitals’ use of artificial intelligence-enabled…
Headline
The AHA provided comments Sept. 30 to the Senate Homeland Security and Governmental Affairs Subcommittee on Disaster Management, District of Columbia and…